Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.78 EUR | -1.07% | -9.74% | -24.04% |
Sales 2024 * | 64.79M 69.23M | Sales 2025 * | 75.94M 81.15M | Capitalization | 61.39M 65.6M |
---|---|---|---|---|---|
Net income 2024 * | -5M -5.34M | Net income 2025 * | -2M -2.14M | EV / Sales 2024 * | 1.32 x |
Net Debt 2024 * | 24.4M 26.07M | Net Debt 2025 * | 22.75M 24.31M | EV / Sales 2025 * | 1.11 x |
P/E ratio 2024 * |
-16.8
x | P/E ratio 2025 * |
-20.6
x | Employees | 311 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.38% |
Latest transcript on BRAIN Biotech AG
1 day | +2.31% | ||
1 week | -5.84% | ||
Current month | -15.94% | ||
1 month | -21.20% | ||
3 months | -23.68% | ||
6 months | -27.68% | ||
Current year | -20.77% |
Managers | Title | Age | Since |
---|---|---|---|
Adriaan Moelker
CEO | Chief Executive Officer | 60 | 20-01-31 |
Director of Finance/CFO | 54 | 20-04-30 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 38 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Majerus
CHM | Chairman | 63 | 19-03-06 |
Stephen Catling
BRD | Director/Board Member | 59 | 20-10-13 |
Director/Board Member | 70 | 20-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 2.78 | -1.07% | 14 114 |
24-04-22 | 2.81 | -1.75% | 14,482 |
24-04-19 | 2.86 | +0.70% | 17,801 |
24-04-18 | 2.84 | -5.33% | 11,880 |
24-04-17 | 3 | -2.60% | 7,421 |
Delayed Quote Xetra, April 23, 2024 at 03:34 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.77% | 65.34M | |
-30.50% | 209M | |
+8.31% | 59.83M |
- Stock Market
- Equities
- BNN Stock